首页 | 本学科首页   官方微博 | 高级检索  
     

年龄相关性白内障防治药物的相关研究进展
引用本文:姜玟彤,刘平. 年龄相关性白内障防治药物的相关研究进展[J]. 国际眼科杂志, 2017, 17(2): 243-246. DOI: 10.3980/j.issn.1672-5123.2017.2.12
作者姓名:姜玟彤  刘平
作者单位:哈尔滨医科大学附属第一医院眼科医院,中国黑龙江省哈尔滨市,150001
基金项目:国家自然科学基金资助项目(No.81470618); 黑龙江省青年科学基金项目(No.QC2013C099)
摘    要:人眼晶状体是一个由上皮细胞以及其分化而来的纤维细胞共同组成的无血管透明器官.随着年龄的增长,晶状体混浊并可在一定程度上影响视力甚至致盲称为年龄相关性白内障(age-related cataract,ARC),其公认的治疗手段为手术治疗,但一部分初发白内障也可通过药物控制其发生发展.本文就ARC相关防治药物及其重要成分进行介绍,并概括总结了近年来药物在白内障防治过程中的临床应用及研究进展.

关 键 词:年龄相关性白内障  药物  应用
收稿时间:2016-10-12
修稿时间:2016-12-27

Research progress of drugs that can control and prevent age-related cataract
Wen-Tong Jiang and Ping Liu. Research progress of drugs that can control and prevent age-related cataract[J]. International Eye Science, 2017, 17(2): 243-246. DOI: 10.3980/j.issn.1672-5123.2017.2.12
Authors:Wen-Tong Jiang and Ping Liu
Affiliation:Eye Hospital, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China and Eye Hospital, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Abstract:The lens is a transparent tissue without vessel, which is mainly composed of a layer of epithelium cells and differentiating fiber cells. With aging, lens opacity can deteriorate vision significantly and even result in blindness, which is termed as age-related cataract(ARC). A fully developed treatment method of ARC is surgery, while a few cataracts in the initial stage can be suppressed via drugs efficiently.This paper introduced relevant drugs and important ingredients that can suppress and prevent ARC, and then summarizes clinical applications and existing researches with respect to drug treatments in the process of cataract suppression and treatment.
Keywords:age-related cataract   drug   application
本文献已被 万方数据 等数据库收录!
点击此处可从《国际眼科杂志》浏览原始摘要信息
点击此处可从《国际眼科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号